Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Ovize

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|September 26, 2017
Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction　- Relationship With Infarct Size, Adverse Remodeling, and Events at 1 YearLéo Cuenin, Sophie Lamoureux, Mathieu Schaaf, et al.
Journal of Cardiology|June 29, 2015
Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patientsMathieu Julien Schaaf, Nathan Mewton, Gilles Rioufol, et al.
Nature Communications|June 8, 2023
SERCA2 phosphorylation at serine 663 is a key regulator of CaFabrice Gonnot, Laura Boulogne, Camille Brun, et al.
International Journal of Cardiology|June 22, 2017
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trialsGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Cardiovascular Research|April 29, 2017
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the HeartDerek J Hausenloy, David Garcia-Dorado, Hans Erik Bøtker, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trialFrançois Roubille, Antoine Micheau, Stéphane Combes, et al.
Data in Brief|August 11, 2017
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Cardiovascular Research|September 2, 2017
Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? ReplyDerek J Hausenloy, David Garcia-Dorado, Hans Erik Bøtker, et al.
JAMA Cardiology|July 20, 2016
Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical TrialLaurent Argaud, Martin Cour, Pierre-Yves Dubien, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 16, 2025
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)Aliya A Khan, Hajar AbuAlrob, Dalal S Ali, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Circulation Journal : Official Journal of the Japanese Circulation Society|September 26, 2017
Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction　- Relationship With Infarct Size, Adverse Remodeling, and Events at 1 YearLéo Cuenin, Sophie Lamoureux, Mathieu Schaaf, et al.
Journal of Cardiology|June 29, 2015
Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patientsMathieu Julien Schaaf, Nathan Mewton, Gilles Rioufol, et al.
Nature Communications|June 8, 2023
SERCA2 phosphorylation at serine 663 is a key regulator of CaFabrice Gonnot, Laura Boulogne, Camille Brun, et al.
International Journal of Cardiology|June 22, 2017
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trialsGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Cardiovascular Research|April 29, 2017
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the HeartDerek J Hausenloy, David Garcia-Dorado, Hans Erik Bøtker, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trialFrançois Roubille, Antoine Micheau, Stéphane Combes, et al.
Data in Brief|August 11, 2017
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Cardiovascular Research|September 2, 2017
Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? ReplyDerek J Hausenloy, David Garcia-Dorado, Hans Erik Bøtker, et al.
JAMA Cardiology|July 20, 2016
Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical TrialLaurent Argaud, Martin Cour, Pierre-Yves Dubien, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 16, 2025
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)Aliya A Khan, Hajar AbuAlrob, Dalal S Ali, et al.
Pageof 22